Literature DB >> 17623689

Antibiotic-lock therapy and erythromycin for treatment of catheter-related Candida parapsilosis and Staphylococcus aureus infections.

Chao-Yi Wu, Ping-Ing Lee.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17623689     DOI: 10.1093/jac/dkm262

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  6 in total

1.  Liposomal amphotericin B displays rapid dose-dependent activity against Candida albicans biofilms.

Authors:  Gordon Ramage; Anto Jose; Leighann Sherry; David F Lappin; Brian Jones; Craig Williams
Journal:  Antimicrob Agents Chemother       Date:  2013-02-19       Impact factor: 5.191

Review 2.  Antifungal lock therapy.

Authors:  Carla J Walraven; Samuel A Lee
Journal:  Antimicrob Agents Chemother       Date:  2012-10-15       Impact factor: 5.191

Review 3.  What Could Be the Role of Antifungal Lock-Solutions? From Bench to Bedside.

Authors:  Christine Imbert; Blandine Rammaert
Journal:  Pathogens       Date:  2018-01-06

Review 4.  Antifungal lock therapy: an eternal promise or an effective alternative therapeutic approach?

Authors:  R Kovács; L Majoros
Journal:  Lett Appl Microbiol       Date:  2022-01-30       Impact factor: 2.813

Review 5.  The Role of Antifungals against Candida Biofilm in Catheter-Related Candidemia.

Authors:  Emilio Bouza; Jesús Guinea; María Guembe
Journal:  Antibiotics (Basel)       Date:  2014-12-25

6.  Activity of Amphotericin B and Anidulafungin Combined with Rifampicin, Clarithromycin, Ethylenediaminetetraacetic Acid, N-Acetylcysteine, and Farnesol against Candida tropicalis Biofilms.

Authors:  Marcelo Ernesto Fernández-Rivero; José L Del Pozo; Amparo Valentín; Araceli Molina de Diego; Javier Pemán; Emilia Cantón
Journal:  J Fungi (Basel)       Date:  2017-03-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.